news
Petrovax Pharm to launch exports of medicinal products to South Africa
The Russian biopharmaceutical company Petrovax Pharm has obtained marketing authorization for its original medicinal product Polyoxidonium® in the Republic of Botswana
Petrovax Pharm presents immuno-oncology innovation at opening of new Moscow City Oncology Hospital No. 62 Complex in Skolkovo
A Study Evaluating Longidaza® Published in Urologia Journal: Combination Treatment Reduced the Risk of Chronic Prostatitis Recurrence Nearly Fourfold
Russia and China expand partnership in pharmaceuticals and biotechnology
A Russian compound becomes the first in the world to demonstrate a significant improvement of exercise tolerance among patients with post-COVID lung injury in a multicenter randomized controlled trial
Petrovax Pharm joins industry discussion on expanding access to innovative therapy at Forum in Uzbekistan
Measures to accelerate market access for innovative medicines discussed at SPIEF
RANEPA and Petrovax Pharm to Assess the Pharmaceutical Industry’s Contribution to Russia’s Economic and Scientific Development
Petrovax Pharm and the Union of Russian Pediatricians sign agreement at SPIEF to promote a culture of vaccination
